OPTIRAY 350

LOE Approaching

ioversol

NDAINJECTIONINJECTABLE

Approved

May 1998

Lifecycle

LOE Approaching

Competitive Pressure

30/100

Mechanism of Action

X-Ray Contrast Activity

Pharmacologic Class:

Radiographic Contrast Agent

Company

France - Villepinte

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers